Condensed Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Operating activities:
Net (loss) income	$ (12,828)	$ 8,068
Adjustments to reconcile net (loss) income to net cash used for operating activities:
Depreciation, amortization, and impairment	207	325
Share-based compensation	1,580	344
Amortization of debt issuance costs and discounts	2,673	56
Other, net	32	(260)
Changes in operating assets and liabilities:
Trade and other receivables, net	147	(2,217)
Inventories	(965)	(1,201)
Prepaid expenses and other assets	(253)	(195)
Accounts payable	1,284	2,494
Accrued expenses and other liabilities	(1,873)	(3,472)
Deferred revenue	(388)	4,874
Net cash (used for) provided by operating activities	(10,384)	8,816
Investing activities:
Capital expenditures	(29)	(2)
Net cash used for investing activities	(29)	(2)
Financing activities:
Proceeds from exercise of stock options, net	539	0
Repayment of debt principal including lease liabilities	(5)	(9,086)
Premium paid to retire debt	0	(1,027)
Payments for taxes on share-based compensation	(893)	(8)
Net cash provided by (used for) financing activities	81,741	(9,205)
Net increase (decrease) in cash and cash equivalents	71,328	(391)
Cash and cash equivalents:
Cash and cash equivalents at beginning of period	23,872	27,273
Cash and cash equivalents at end of period	95,200	26,882
Supplemental disclosures of cash flow information:
Cash payments for interest	1,003	1,466
Costs associated with public offering in Accounts Payable	313	0
Proceeds from common stock issued under public equity offering, net - ATM
Financing activities:
Proceeds from common stock issued under public equity offering	11,974	916
Proceeds from common stock issued under public equity offering, net
Financing activities:
Proceeds from common stock issued under public equity offering	$ 70,126	$ 0